Emergent BioSolutions Inc - Company Profile
Powered by 
All the sales intelligence you need on Emergent BioSolutions Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Emergent BioSolutions Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Emergent BioSolutions Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Emergent BioSolutions Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Emergent BioSolutions Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Zsolt Harsanyi
Chairman Executive BoardDr. Zsolt Harsanyi has been the Chairman of the company since 2022. Prior to this, he served as the Chairman of N-Gene Research Laboratories Inc. Previously, he served as the Chief Executive Officer and Chairman of Exponential Biotherapies Inc from 2004 to 2011. Dr. Harsanyi also served as the Director of Aptevo Therapeutics Inc and President at Porton International Plc.
Joseph C. Papa
Director; President; Chief Executive Officer Executive BoardMr. Joseph C. Papa has been the Chief Executive Officer, Director, and President of the company since 2024. Prior to this, he served as the Chief Executive Officer and Chairman at Bausch and Lomb Corporation. Previously, he served as the Chief Executive Officer and Chairman of Bausch Health. Mr. Papa also served as the Chairman and Chief Executive Officer of Perrigo. Currently, he serves as the Chairman of the Board of SparingVision.
Richard S. Lindahl
Chief Financial Officer; Executive Vice President Senior ManagementMr. Richard S. Lindahl has been the Chief Financial Officer and Executive Vice President of the company since 2018. Prior to this, he served as Treasurer of the company from 2018 to 2025. Previously, he served as the Chief Financial Officer of CEB Inc from 2009 to 2017. He served as the Senior Vice President, Vice President and Treasurer of Sprint Nextel Corporation from 2006 to 2008.
Simon Lowry
Head - Research and Development; Chief Medical Officer Senior ManagementMr. Simon Lowry has been the Chief Medical Officer and Head of Research and Development of the company since 2024. Prior to this, he served as the Chief Executive Officer of Mysthera Therapeutics AG from 2023 to 2024. He served as Chief Medical Officer of Zenas BioPharma from 2022 to 2023. He served as Chief Medical Officer of Kinevant Sciences from 2020 to 2022. Mr. Lowry served as Head of Immunology Research & Development of Roivant Sciences from 2019 to 2021.
Stephanie Duatschek
Chief Global Strategy and Franchise Development Officer Senior ManagementMs. Stephanie Duatschek is the Chief Global Strategy and Franchise Development Officer of the company.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer